Trace elements in glucometabolic disorders: an update
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Many trace elements, among which metals, are indispensable for proper functioning of a myriad of biochemical reactions, more particularly as enzyme cofactors. This is particularly true for the vast set of processes involved in regulation of glucose homeostasis, being it in glucose metabolism itself or in hormonal control, especially insulin. The role and importance of trace elements such as chromium, zinc, selenium, lithium and vanadium are much less evident and subjected to chronic debate. This review updates our actual knowledge concerning these five trace elements. A careful survey of the literature shows that while theoretical postulates from some key roles of these elements had led to real hopes for therapy of insulin resistance and diabetes, the limited experience based on available data indicates that beneficial effects and use of most of them are subjected to caution, given the narrow window between safe and unsafe doses. Clear therapeutic benefit in these pathologies is presently doubtful but some data indicate that these metals may have a clinical interest in patients presenting deficiencies in individual metal levels. The same holds true for an association of some trace elements such as chromium or zinc with oral antidiabetics. However, this area is essentially unexplored in adequate clinical trials, which are worth being performed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogenesis of insulin resistance in skeletal muscle
Abdul-Ghani, M. A., & DeFronzo, R. A. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/476279 · Cited by 670
Antioxidant effect of zinc in humans
Prasad, A. S., Bao, B., Beck, F. W. J., Kucuk, O., & Sarkar, F. H. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.07.007 · Cited by 520 · cited 1×
“Zn can also reduce cytokines such as IL-1b as well as NF B [87,88].”
BackgroundClinical, immunological, anti-inflammatory and antioxidant roles of zinc
Prasad, A. S. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2007.10.013 · Cited by 454 · cited 1×
“Concerning metabolic diseases (insulin resistance, metabolic syndrome, diabetes), Zn is considered important mainly because 1) it plays a major role in the stabilization of insulin hexamers and the pancreatic storage of the hormone [73] and 2) it is an efficient antioxidant [74], while oxidative stress is considered t…”
BackgroundEffect of Chromium Supplementation on Glucose Metabolism and Lipids
Balk, E. M., Tatsioni, A., Lichtenstein, A. H., Lau, J., & Pittas, A. G. (2007) · Diabetes Care · doi:10.2337/dc06-0996 · Cited by 294
Prospective study of zinc intake and risk of type 2 diabetes in women
Sun, Q., van Dam, R. M., Willett, W. C., & Hu, F. B. (2009) · Diabetes Care · doi:10.2337/dc08-1913 · Cited by 196 · cited 1×
“High Zn slightly reduced the risk for type 2 diabetes in a prospective study performed in 8300 women and the effect was limited to the Zn-deficient subgroup [103].”
BackgroundCellular chromium enhances activation of insulin receptor kinase
Wang, H., Kruszewski, A., & Brautigan, D. L. (2005) · Biochemistry · doi:10.1021/bi0473152 · Cited by 121 · cited 1×
“Crpicolinate was shown to induce various effects: increase in AMPKinase and p38 MAPkinase activities [20], increase in receptor phosphorylation [21] and increase in insulin receptor mRNA (in addition to mRNA for GLUT-4, glycogen synthase and UCP3) [22].”
BackgroundHenriksen, E. J., Kinnick, T. R., Teachey, M. K., O'Keefe, M. P., Ring, D., Johnson, K. W., & Harrison, S. D. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00346.2002 · Cited by 108 · cited 1×
“The interest in Li is based on its ability to inhibit GSK3 [158,159], a key enzyme regulating tissue glycogen levels [160,161].”
Background
Cited by
A REVIEW ON ROLE OF ANTIOXIDANTS IN DIABETES
Rajendiran, D., Packirisamy, S., & Gunasekaran, K. (2018) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2018.v11i2.23241 · Cited by 92
Foroozanfard, F., Jamilian, M., Jafari, Z., Khassaf, A., Hosseini, A., Khorammian, H., & Asemi, Z. (2015) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0035-1548790 · Cited by 55
“In addition, zinc anti-oxidative properties may delay progression of insulin resistance [25].”
Rech, M., To, L., Tovbin, A., Smoot, T., & Mlynarek, M. (2014) · Nutrition in Clinical Practice · doi:10.1177/0884533613515724 · Cited by 50
Suliburska, J., Bogdanski, P., Szulinska, M., Pupek-Musialik, D., & Jablecka, A. (2014) · European Journal of Nutrition · doi:10.1007/s00394-013-0533-7 · Cited by 47
“Interestingly, it has been reported that diabetics have elevated levels of copper [8].”
BackgroundEngelken, J., Espadas, G., Mancuso, F. M., Bonet, N., Scherr, A.-L., Jímenez-Álvarez, V., Codina-Solà, M., Medina-Stacey, D., Spataro, N., Stoneking, M., et al. (2016) · Molecular Biology and Evolution · doi:10.1093/molbev/msv267 · Cited by 31
Metadata
- Authors
- Wiernsperger, N., & Rapin, J.
- Venue
- Diabetology & Metabolic Syndrome
- Published
- 2010-12
- Volume
- 2
- Issue
- 1
- Pages
- 70-70
- ISSN
- 1758-5996 (ISSN-L)
- OpenAlex
- W2148955263
- Cited by
- 155
- References
- 7
- FWCI
- 5.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Trace elements in glucometabolic disorders: an update. https://app.cochat.ai/papers/10.1186/1758-5996-2-70
- The paper
- Wiernsperger, N., & Rapin, J. (2010). Trace elements in glucometabolic disorders: an update. Diabetology & Metabolic Syndrome. https://doi.org/10.1186/1758-5996-2-70
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.